LPL and Alzheimer disease: Our meta-analysis indicates that LPL Ser447Ter polymorphism is a protective factor of AD in the Northern-American population (OR = 0.56, 95% CI = 0.35–0.91, P = 0.02) and thus supports this above speculation.